Eprazinone is a mucolytic and antitussive agent primarily indicated for treating respiratory conditions by reducing mucus viscosity and relieving bronchospasms. As a pharmaceutical compound designed to… Read more
Eprazinone is a mucolytic and antitussive agent primarily indicated for treating respiratory conditions by reducing mucus viscosity and relieving bronchospasms. As a pharmaceutical compound designed to facilitate airway clearance, it functions by modifying the physical properties of bronchial secretions. This category features high-quality reference standards of Eprazinone API, along with its associated impurities, metabolites, and stable isotope-labelled compounds. These materials are essential tools for pharmaceutical laboratories engaged in rigorous analytical testing and method validation. By utilizing these characterized reference materials, researchers can accurately perform impurity profiling, monitor degradation pathways, and ensure precise quantification during stability studies. These standards play a critical role in quality control, enabling analysts to maintain compliance with regulatory guidelines throughout the drug development process and supporting the consistent evaluation of Eprazinone in various biological and chemical matrices.